Abbott | Gewinn Vor Steuern

Aktienkurs
110.83
Täglich Wechseln
1.75 1.60%
Monatlich
-12.76%
Jährlich
-14.13%
Q1 Prognose
107.43




Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.36B 178M 2025-12
Agilent USD 443M 22M 2025-06
AtriCure USD -86K 5.84M 2025-09
Baxter International USD 121M 12M 2025-09
Becton, Dickinson and Co. USD 510M 193M 2025-09
Bio-Rad Laboratories USD 82.9M 331.1M 2025-09
Boston Scientific USD 938M 3M 2025-09
Cooper Companies USD 254.2M 27.6M 2025-06
Danaher USD 1.08B 421M 2025-09
Dexcom USD 300M 58.9M 2025-09
Edwards Lifesciences USD 400.2M 33.7M 2025-06
Globus Medical USD 188.17M 84.5M 2025-06
Hologic USD 229.7M 2.3M 2025-12
Insulet USD 122.8M 94.4M 2025-09
Integra LifeSciences USD -6.82M 524.13M 2025-09
Intuitive Surgical USD 855.2M 23.1M 2025-09
J&J USD 4.97B 2.53B 2025-12
Masimo USD 74.9M 19.5M 2025-09
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 73.18M 29.8M 2025-09
Pfizer USD 3.33B 290M 2025-09
Smith & Nephew USD 469M 70M 2025-12
Solventum Corp USD 511M 149M 2025-09
Stryker USD 1.03B 13M 2025-09
Tandem Diabetes Care USD -57.72M 64.37M 2025-06
Teleflex USD -438.58M 573.82M 2025-09
Terumo JPY 45.95B 9.31B 2025-09
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Zimmer Biomet Holdings USD 418.7M 194.1M 2025-09


Abbott Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.